Puma Biotechnology, Inc. (PBYI)
NASDAQ: PBYI · Real-Time Price · USD
6.22
+0.17 (2.81%)
At close: Mar 9, 2026, 4:00 PM EDT
5.90
-0.32 (-5.14%)
After-hours: Mar 9, 2026, 6:16 PM EDT
Puma Biotechnology Employees
Puma Biotechnology had 179 employees as of December 31, 2025. The number of employees increased by 7 or 4.07% compared to the previous year.
Employees
179
Change (1Y)
7
Growth (1Y)
4.07%
Revenue / Employee
$1,275,816
Profits / Employee
$173,804
Market Cap
316.45M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Cabaletta Bio | 151 |
| Nautilus Biotechnology | 124 |
| Silence Therapeutics | 116 |
| C4 Therapeutics | 110 |
| Rezolute | 75 |
| ALX Oncology Holdings | 44 |
| Protara Therapeutics | 33 |
| Avalo Therapeutics | 23 |
PBYI News
- 10 days ago - Puma Biotechnology, Inc. (PBYI) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 11 days ago - Puma Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results - Business Wire
- 14 days ago - Puma Biotechnology to Present at TD Cowen's 46th Annual Health Care Conference - Business Wire
- 25 days ago - Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2025 Financial Results - Business Wire
- 4 weeks ago - Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 2 months ago - Puma Biotechnology Added to the NASDAQ Biotechnology Index (NBI) - Business Wire
- 4 months ago - Puma Biotechnology: Step By Step In Making A Transition - Seeking Alpha
- 4 months ago - Puma Biotechnology, Inc. (PBYI) Q3 2025 Earnings Call Transcript - Seeking Alpha